687
Views
0
CrossRef citations to date
0
Altmetric
Letter

Reply to letter from Alvarez et al.

ORCID Icon, , &
Pages 696-697 | Received 29 Jul 2020, Accepted 16 Aug 2020, Published online: 29 Oct 2020

References

  • Ruiz-Aragón, Ruiz-Aragón J, Gani R, Márquez S, Alvarez P. Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain. Hum Vaccin Immunother. 2020:1–7. published online February 10th, 2020. doi:10.1080/21645515.2020.1712935.
  • Boikos T. Relative effectiveness of the cell-cultured quadrivalent influenza vaccine compared to standard, egg-derived quadrivalent influenza vaccines in preventing influenza-like illness in 20172018. Clin Infect Dis. 2019. published online April 7th, 2020
  • Boikos C, Sylvester GC, Sampalis JS, Mansi JA. Relative effectiveness of the cell-cultured quadrivalent influenza vaccine compared to standard, egg-derived quadrivalent influenza vaccines in preventing influenza-like illness in 2017-2018 [published online ahead of print, 2020 Apr 7]. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa371.
  • Izurieta HS, Chillarige Y, Kelman J, Wei Y, Lu Y, Xu W, Lu M, Pratt D, Chu S, Wernecke M, et al. Relative effectiveness of cell-cultured and egg-based influenza vaccines among the U.S. elderly, 2017-18. J Infect Dis. 2019;220:1255–64. doi:10.1093/infdis/jiy716.
  • Izurieta HS, Chillarige Y, Kelman J, Wei Y, Lu Y, Xu W, Lu M, Pratt D, Wernecke M, MaCurdy T, Forshee R. Relative effectiveness of influenza vaccines among the U.S. elderly, 2018-19. J Infect Dis. 2020. doi:10.1093/infdis/jiaa080.
  • Demarcus L, Shoubaki L, Federinko S. Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017-2018 influenza season. Vaccine. 2019;37:4015–21. doi:10.1016/j.vaccine.2019.06.004.
  • Klein NP, Fireman B, Goddard K, Zerbo O, Asher J, Zhou J, King J, Lewis N. Vaccine effectiveness of flucelvax relative to inactivated influenza vaccine during the 2017-18 influenza season in Northern California. Presented at the lnfectious Disease (ID) Week Congress in San Francisco in October 2018. https://idsa.confex.com/idsa/2018/webprogram/Paper74111.html
  • Bruxvoort KJ, Luo Y, Ackerson B, Tanenbaum HC, Sy LS, Gandhi A, Tseng HF. Comparison of Vaccine Effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018. Vaccine. 2019;37:5807–11. doi:10.1016/j.vaccine.2019.08.024.
  • Restivo V, Costantino C, Bono S, Maniglia M, Marchese V, Ventura G, Casuccio A, Tramuto F, Vitale F. Influenza vaccine effectiveness among high-risk groups: A systematic literature review and meta-analysis of case-control and cohort studies. Hum Vaccin Immunother. 2018;14(3):724–35. doi:10.1080/21645515.2017.1321722.
  • Vallejo-Torres L, Garcia-Lorenzo B, Serrano-Aguilar P. Estimating a cost-effectiveness threshold for the Spanish NHS. Health Econ. 2018;27(4):746–61. doi:10.1002/hec.3633.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.